Shanghai Pharmaceuticals nets $397m in H-share offering
Shanghai Pharmaceuticals Holding Co raised HK$3.1bn ($396.6m) through an H-share placement on Thursday, its biggest follow-on offering yet.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: